FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079244274> ?p ?o ?g. }

• W2079244274 endingPage "119" @default.
• W2079244274 startingPage "105" @default.
• W2079244274 abstract "[DMet2, Pro5]Enkephalin (I) and [DMet2, Pro5]enkephalinamide (II), two of the more potent opioid peptides, have been studied by 1H and 13C NMR and by theoretical calculations. Their biological activity is tentatively related to their conformational behaviour. A cis⇌ trans equilibrium around the Phe-Pro bond is brought about by the terminal prolyl residue. The cis/trans ratios lie around 50/50 for peptide I (55%cis in dimethylsulfoxide, 35 %cis in water) and around 20/80 for peptide II, the more potent compound, in both the solvents. Almost all the signals, both in 1H and 13C spectra, give separate resonances for the cis and trans rotamers, in dimethylsulfoxide as well as in water. A temperature variation allows one to determine the rotational barrier (ΔG+TC, ∼ 81.5 kJ/mol) for the cis⇌trans interconversion. The analysis of the vicinal coupling constants and theoretical calculations suggests that Tyr-dMet-Gly-Phe-Pro exists as a class of highly puckered conformations with short end-to-end distances at r= 0.4 nm and r= 0.6 nm for the trans and cisconfigurations respectively. The populations of the side-chain rotamers are predominantly trans/gauche (tg) for the tyrosine residue. This feature, which is quite general in enkephalins, is related to the crucial role of the tyramine moiety for opioid activity. The orientation of the Phe-4 side-chain is independent of the spatial disposition of the following prolyl residue. pH titrations provide evidence for the existence of head-to-tail interactions. Hence, in (2H6)dimethylsulfoxide, and to a lesser extent in 2H2O, the titration of the Pro-5 residue is clearly felt on the Tyr-1 moiety, whereas the deprotonation of this latter residue leads to changes in the chemical shifts of the pyrrolidine ring protons. The β protons of the Tyr-1 and Phe-4 residues are strongly magnetically nonequivalent; the opposite is true for Met-enkephalin where they show the same chemical shifts below pH 6. The titration effects suggest that no strong conformational change occurs during the amino or carboxyl group titration and indicate an important steric hindrance on the NMR time scale for the two aromatic side chains. The 13C NMR spectra of peptide I in (2H6)dimethylsulfoxide and in a mixture of (2H6)dimethylsulfoxide/2H2O (507sol;50) exhibit for almost all the resonances well-separated signals, corresponding to the cis and trans conformers. The large changes in 13C chemical shifts occurring Qn the backbone and side-chain carbons during the titration steps confirm the through-space effects already deduced from the proton titration curves. Hence, several C-α (Met-2, Phe-4) and C-β (Met-2, Pro-5) atoms are affected by both the titrations of the two terminal parts of the peptide. Such effects were not observed in Met-enkephalin or Leu-enkephalin. The 13C relaxation times for the cis and trans rotamers were compared, in (2H6)dimethylsulfoxide, under strictly the same conditions. All the NT1 values are small and lie in the same range both for the carbons of the peptide backbone and for the carbons of the lateral chains. The restriction in the segmental motion of the sidechains is shown by the NT1 values of the 13C of the pyrrolidine ring and by the C-β and C-γ of the methionine residue which lie near those of the backbone carbons. No significant internal rotation of the aromatic ring of the tyrosyl residue seems to occur. A restricted degree of freedom for the C-α-C-β carbons is shown for the phenylalanyl residue which contrasts with Metenkephalin, Leu-enkephalin and a larger peptide such as α-endorphin. All these results, both in dimethylsulfoxide and in water seem to exclude a random conformation for the compounds I and II. The titration effects are related to strong compression effects due to the presence of a d met-2 residue wedged between two relatively inflexible aromatic residues. Moreover. the results indicate that, despite the absence of a classical β-turn, these compounds exhibit folded structures induced by their high content of hydrophobic side chains. The conformational behaviour of peptides I and II can be related to their high specificity for the μ-receptor site. Hence, it can be noticed that, in the trans form of the peptides the first part, Tyr-DMet-Gly, may adopt the angular requirements (ψ1=−169°, φ2= plus;83°, ψ2=+53°, φ3=+150°) of the active conformation that we recently proposed for the interaction at the μ-receptor site. Moreover it is possible that the trans form, more populated in the highly potent compound II, might better represent the active form in the interaction at the receptor site." @default.
• W2079244274 created "2016-06-24" @default.
• W2079244274 creator A5032132304 @default.
• W2079244274 creator A5037019808 @default.
• W2079244274 creator A5067880948 @default.
• W2079244274 creator A5074282168 @default.
• W2079244274 date "2005-03-03" @default.
• W2079244274 modified "2023-10-11" @default.
• W2079244274 title "Studies of the Conformational Behaviour and Preferential Interactions with Opiate Receptors of the cis and trans Forms of [dMet2, Pro5]Enkephalin and [dMet2, Pro5]Enkephalinamide by 1H and 13C NMR, Theoretical Calculations and 13C Relaxation Measurements" @default.
• W2079244274 cites W1238935559 @default.
• W2079244274 cites W1589344206 @default.
• W2079244274 cites W1608641269 @default.
• W2079244274 cites W1964006288 @default.
• W2079244274 cites W1965023247 @default.
• W2079244274 cites W1965166997 @default.
• W2079244274 cites W1981035630 @default.
• W2079244274 cites W1981200951 @default.
• W2079244274 cites W1992534769 @default.
• W2079244274 cites W2002085096 @default.
• W2079244274 cites W2007979128 @default.
• W2079244274 cites W2009073047 @default.
• W2079244274 cites W2010051841 @default.
• W2079244274 cites W2010431328 @default.
• W2079244274 cites W2011418877 @default.
• W2079244274 cites W2014407911 @default.
• W2079244274 cites W2015766640 @default.
• W2079244274 cites W2020939010 @default.
• W2079244274 cites W2021206227 @default.
• W2079244274 cites W2021212968 @default.
• W2079244274 cites W2023795180 @default.
• W2079244274 cites W2025669222 @default.
• W2079244274 cites W2029212708 @default.
• W2079244274 cites W2038089016 @default.
• W2079244274 cites W2038992791 @default.
• W2079244274 cites W2040590747 @default.
• W2079244274 cites W2042193532 @default.
• W2079244274 cites W2042687048 @default.
• W2079244274 cites W2043031841 @default.
• W2079244274 cites W2045079655 @default.
• W2079244274 cites W2057065146 @default.
• W2079244274 cites W2057100904 @default.
• W2079244274 cites W2064070133 @default.
• W2079244274 cites W2066123250 @default.
• W2079244274 cites W2067617578 @default.
• W2079244274 cites W2070169252 @default.
• W2079244274 cites W2073469031 @default.
• W2079244274 cites W2075811628 @default.
• W2079244274 cites W2076523452 @default.
• W2079244274 cites W2082366516 @default.
• W2079244274 cites W2089815496 @default.
• W2079244274 cites W2093388732 @default.
• W2079244274 cites W3004713269 @default.
• W2079244274 cites W3005114789 @default.
• W2079244274 doi "https://doi.org/10.1111/j.1432-1033.1980.tb06145.x" @default.
• W2079244274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6257512" @default.
• W2079244274 hasPublicationYear "2005" @default.
• W2079244274 type Work @default.
• W2079244274 sameAs 2079244274 @default.
• W2079244274 citedByCount "13" @default.
• W2079244274 countsByYear W20792442742013 @default.
• W2079244274 crossrefType "journal-article" @default.
• W2079244274 hasAuthorship W2079244274A5032132304 @default.
• W2079244274 hasAuthorship W2079244274A5037019808 @default.
• W2079244274 hasAuthorship W2079244274A5067880948 @default.
• W2079244274 hasAuthorship W2079244274A5074282168 @default.
• W2079244274 hasBestOaLocation W20792442741 @default.
• W2079244274 hasConcept C115624301 @default.
• W2079244274 hasConcept C155518411 @default.
• W2079244274 hasConcept C176788430 @default.
• W2079244274 hasConcept C178790620 @default.
• W2079244274 hasConcept C185592680 @default.
• W2079244274 hasConcept C18705241 @default.
• W2079244274 hasConcept C204921945 @default.
• W2079244274 hasConcept C2776568683 @default.
• W2079244274 hasConcept C2781338088 @default.
• W2079244274 hasConcept C32909587 @default.
• W2079244274 hasConcept C521977710 @default.
• W2079244274 hasConcept C71240020 @default.
• W2079244274 hasConcept C8010536 @default.
• W2079244274 hasConceptScore W2079244274C115624301 @default.
• W2079244274 hasConceptScore W2079244274C155518411 @default.
• W2079244274 hasConceptScore W2079244274C176788430 @default.
• W2079244274 hasConceptScore W2079244274C178790620 @default.
• W2079244274 hasConceptScore W2079244274C185592680 @default.
• W2079244274 hasConceptScore W2079244274C18705241 @default.
• W2079244274 hasConceptScore W2079244274C204921945 @default.
• W2079244274 hasConceptScore W2079244274C2776568683 @default.
• W2079244274 hasConceptScore W2079244274C2781338088 @default.
• W2079244274 hasConceptScore W2079244274C32909587 @default.
• W2079244274 hasConceptScore W2079244274C521977710 @default.
• W2079244274 hasConceptScore W2079244274C71240020 @default.
• W2079244274 hasConceptScore W2079244274C8010536 @default.
• W2079244274 hasIssue "1" @default.
• W2079244274 hasLocation W20792442741 @default.
• W2079244274 hasLocation W20792442742 @default.
• W2079244274 hasOpenAccess W2079244274 @default.
• W2079244274 hasPrimaryLocation W20792442741 @default.
• W2079244274 hasRelatedWork W1972480557 @default.

• next